ALLOGENE THERAPEUTICS
Allogene Therapeutics is a clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple allogeneic T cell product candidates utilizing validated gene editing and advanced proprietary cell manufacturing technologies. Its pipeline includes UCART19 which is developed for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL), as well as several preclinical allogeneic CAR T therapies.
ALLOGENE THERAPEUTICS
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
2017-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.allogene.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
531.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Akouos
Akouos is a biotechnology company focusing on restoring and preserving hearing.
AlgoTherapeutix
AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Centessa Pharmaceuticals
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
GeneTx Biotherapeutics
GeneTx Biotherapeutics is a biotechnology company that focuses on developing therapeutics for the treatment of Angelman syndrome.
Glycologix
Glycologix is a biotechnology company that specializes in R&D of biomaterials for the protection and repair of soft tissues.
Graphite Bio
Graphite Bio is a next-generation gene editing company that is driven to apply our breakthrough technology.
GRO Biosciences
GRO Biosciences is a biotechnology company that expands the amino acid alphabet to overcome the limitations of protein therapeutics.
Medeor Therapeutics
Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
PreDxion Bio
PreDxion Bio is revolutionizing testing and treatment through low-cost, user-friendly at-home diagnostics.
Selva Therapeutics
Selva Therapeutics is a privately held biotechnology company dedicated to the development of therapeutics for infectious diseases.
Shape Therapeutics
A biotechnology company developing RNA technologies to shape the future of gene therapy
Stalicla
STALICLA is a Swiss biotechnology company developing precision medicine treatments for patients with Neurodevelopmental disorders
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Franklin Templeton Investments
Franklin Templeton Investments investment in Convertible Note - Allogene Therapeutics
Jennison Associates
Jennison Associates investment in Convertible Note - Allogene Therapeutics
venBio Select Advisor
venBio Select Advisor investment in Convertible Note - Allogene Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Convertible Note - Allogene Therapeutics
Deerfield Capital Management
Deerfield Capital Management investment in Convertible Note - Allogene Therapeutics
Surveyor Capital
Surveyor Capital investment in Convertible Note - Allogene Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Convertible Note - Allogene Therapeutics
T. Rowe Price
T. Rowe Price investment in Convertible Note - Allogene Therapeutics
TPG
TPG investment in Series A - Allogene Therapeutics
Gilead Sciences
Gilead Sciences investment in Series A - Allogene Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-28 | Allogene Therapeutics Appoints Susan Lundeen as Chief People Officer |
Official Site Inspections
http://www.allogene.com Semrush global rank: 1.95 M Semrush visits lastest month: 11.07 K
- Host name: allogene.therevoltgroup.com
- IP address: 138.197.7.37
- Location: Clifton United States
- Latitude: 40.8364
- Longitude: -74.1403
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07014
